DiscoverLet's Talk RiskCOVID-19 Vaccines from a Risk-Based Perspective
COVID-19 Vaccines from a Risk-Based Perspective

COVID-19 Vaccines from a Risk-Based Perspective

Update: 2021-05-11
Share

Description

What does vaccination development look like from a risk-based perspective? Seth Guikema, Ph.D., University of Michigan, talks with Ben Trump, a member of the Army Corps of Engineers, about the complex process of COVID-19 vaccine development. Between accounting for technical science perspectives, considering various forms of regulatory approval, and addressing risk assessment-based challenges, parsing through the process for COVID-19 emergency use vaccination efforts can seem arduous. Disclaimer: Opinions are the speakers' alone, and not representative of the US Government or any state government.

Comments 
In Channel
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

COVID-19 Vaccines from a Risk-Based Perspective

COVID-19 Vaccines from a Risk-Based Perspective

Society for Risk Analysis